Back to News
Market Impact: 0.15
BMO Capital Initiates Coverage of Ardent Health at Market Perform
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
BMO Capital initiated coverage of Ardent Health (NYSE: ARDT) on September 23, 2026, with a Market Perform rating. ARDT closed at $10.64 on the rating date, down $0.31, or 2.8%, from its $10.95 close on September 22. The neutral initiation provides limited directional catalyst for the shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ARDT0.00
More News
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- Stifel raises Limbach Holdings stock price target on revenue beat
- AMD shares are primed for a comeback, says Oppenheimer
- CorMedix stock gains as Heron deal adds four products
- Rezolute at Guggenheim: FDA progress lifts rare-disease hopes